Skip to content

Clinical trials

Terminated Lymphoma, Large B-Cell, Diffuse trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Terminated Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20101
20113
20131
20161
20171
20181
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Hoffmann-La Roche2
AbbVie1
Amgen1
European Organisation for Research and Treatment of Cancer - EORTC1
Genmab1
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH1
Pfizer1
Philogen S.p.A.1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse14
Lymphoma, Non-Hodgkin5
Lymphoma4
Lymphoma, Follicular4
Lymphoma, Mantle-Cell4
Burkitt Lymphoma2
Leukemia, Myeloid, Acute2
Lymphoma, B-Cell, Marginal Zone2
Blast Crisis1
Congenital Abnormalities1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.